Lexaria Bioscience (LEXX) Return on Sales (2017 - 2025)
Historic Return on Sales for Lexaria Bioscience (LEXX) over the last 13 years, with Q4 2025 value amounting to 20.62%.
- Lexaria Bioscience's Return on Sales fell 59900.0% to 20.62% in Q4 2025 from the same period last year, while for Nov 2025 it was 20.62%, marking a year-over-year decrease of 59300.0%. This contributed to the annual value of 16.83% for FY2025, which is 44700.0% down from last year.
- Latest data reveals that Lexaria Bioscience reported Return on Sales of 20.62% as of Q4 2025, which was down 59900.0% from 15.44% recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Return on Sales ranged from a high of 0.0% in Q3 2021 and a low of 144.34% during Q4 2021
- Over the past 5 years, Lexaria Bioscience's median Return on Sales value was 18.98% (recorded in 2025), while the average stood at 26.07%.
- As far as peak fluctuations go, Lexaria Bioscience's Return on Sales tumbled by -1443500bps in 2021, and later skyrocketed by 1270000bps in 2022.
- Over the past 5 years, Lexaria Bioscience's Return on Sales (Quarter) stood at 144.34% in 2021, then skyrocketed by 88bps to 17.35% in 2022, then soared by 57bps to 7.48% in 2023, then tumbled by -96bps to 14.63% in 2024, then tumbled by -41bps to 20.62% in 2025.
- Its Return on Sales stands at 20.62% for Q4 2025, versus 15.44% for Q3 2025 and 21.55% for Q2 2025.